- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USA Mitchell Cancer Institute ( Site 0173) Mobile, Alabama, United States
- Banner MD Anderson Cancer Center ( Site 0165) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167) Phoenix, Arizona, United States
- The University of Arizona Cancer Center - North Campus ( Site 0124) Tucson, Arizona, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,121 public trials
2,033 recruiting studies
Lymphoproliferative Disorders trial results
NCT03739814
- Conditions
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
NCT06784752
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Hartford Hospital Hartford, Connecticut, United States
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
NCT06806033
- Conditions
- Cytokine Release Syndrome, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States
NCT06904066
- Conditions
- Blood Cancer, Blood Protein Disorders, Bone Marrow Diseases, +42 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06973187
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Kaiser Permanente Southern California Irvine, California, United States
- University of California San Diego (Ucsd) Moores Cancer Center La Jolla, California, United States
NCT06634589
- Conditions
- B-cell Lymphoma, B-cell Malignancy, Disease Attributes, +15 more
- Locations
-
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- University of Southern California Norris Comprehensive Los Angeles, California, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT06953960
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Southern California /ID# 272414 Los Angeles, California, United States
- Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
- University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214 New York, United States
NCT05884333
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +26 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT07572136
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States